期刊文献+

上海四平社区高血压综合管理药物治疗情况分析 被引量:15

An Analysis of Cooperation Management of Hypertension Treatment in Siping Community of Shanghai
下载PDF
导出
摘要 目的分析社区高血压综合管理用药情况,探索社区医师规范用药,提高社区高血压控制率。方法将四平社区2009年高血压综合管理药物治疗情况进行归纳、分析、总结。结果不同危险分层高血压患者血压控制情况比较差异有统计学意义(2χ=39.75,P<0.05)。低危、中危高血压患者以服用单品种高血压药物为主;高危、极高危高血压患者多需联合用药方能达到较好的控制效果。不同危险分层患者均有使用复方制剂者。随着年龄的增加需联合用药的比例增加。女性应用β-受体阻滞剂和复方制剂较男性多,差异有统计学意义(P<0.05)。结论社区高血压综合干预能有效提高高血压控制率,高血压综合干预药物治疗不可或缺,全科医师规范合理用药尤其重要。 Objective To analyze the cooperation management of hypertension drugs′ administration,explore how community doctor prescribe medicine appropriately,and enhance control rate of hypertension in community.Methods Data which related to the cooperation management of hypertension treatment were generalized,analyzed and summarized from January to December 2009.Results It is indispensable to manage the proper administration cooperatively.Conclusion Cooperative interventions can elevate control rate of hypertension in community.It is extremely important to intervene medical treatment cooperatively.It is especially important for general practitioners to prescribe medicine in an appropriate and rational way.
出处 《中国全科医学》 CAS CSCD 北大核心 2010年第28期3220-3222,共3页 Chinese General Practice
关键词 社区高血压管理 药物治疗 规范用药 Hypertension management in community Medical treatment Appropriate administration
  • 相关文献

参考文献7

二级参考文献38

  • 1张建军,高国梁,董伟峰,严肖峰.尼莫地平在高血压脑出血术后的降压疗效[J].中国新药与临床杂志,2005,24(5):379-382. 被引量:10
  • 2李立明,饶克勤,孔灵芝,姚崇华,向红丁,翟凤英,马冠生,杨晓光,中国居民营养与健康状况调查技术执行组.中国居民2002年营养与健康状况调查[J].中华流行病学杂志,2005,26(7):478-484. 被引量:1782
  • 3UK Prospective Diabetes Study Group.Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)[J].Lancet,1998;352:837-853.
  • 4Hansson L,Zanchetti A,Carruthers SG,et al.Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension:principal results of the Hypertension Optimal Treatment(HOT) randomised trial[J].Lancet,1998 ;351:1755-1762.
  • 5Meurin PP.The ASCOT trial:Clarifying the role of ACE inhibition in the reduction of cardiovascuLar events in patients with hyper[J].Am J Cardio Drugs,2006; 6:327-334.
  • 6Law MR,Wald N J,Rudnieka AR Quantifying effect of stetins on low density lipoprotein cholesterol,ischaemic heart disease,and stroke:systematic review and meta-analysis[J].BMJ,2003; 326:1423-1427.
  • 7Jamerson KA.on behalf of the ACCOMPLISH investigators.Avoiding cardiovascular events in combination therapy in patients living with systolic hypertension[C].Chicago:American College of Cardiology Scientific Scssions,2008-03-31.
  • 8Julius S,Kjeldsen SE,Brunner H,et al.VALUE trial:Long-term blood pressure trends in 13,449 patients with hypertension and high cardiovnscular risk[J].Am J Hypertens,2003;16:544-548.
  • 9Neutel.JM.Prescribing patterns in hypertension:the emerging role of fixed-dose combinations for attaining BP goals in hypertensive patients[J].Curt Med lies Opin,2008 ;24:2389-2401.
  • 10Chrysant SG.Using fixed-dose combination therapies to achieve blood pressure goals[J].Clin Drug lnvestig,2008;28:713-734.

共引文献878

同被引文献129

引证文献15

二级引证文献131

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部